Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?

G Zettinig¹, A Tanew, G Fischer

¹Department of Nuclear Medicine, Ludwig Boltzmann Institute for Nuclear Medicine, University of Vienna, Vienna, Austria. georg.zetting@univie.ac.at

Clinical and Experimental Immunology

|February 4, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Effect of Water-Filtered Infrared-A (wIRA) Radiation on Morphea: An Intra-Individual Pilot Split-Study.

Experimental dermatology·2026

Same author

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Successful treatment of calcinosis cutis with a topical sodium thiosulphate preparation containing 20% zinc oxide in a patient with sclerotic graft-versus-host disease.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

Miliarial type perifollicular B-cell pseudolymphoma: an easily overlooked rare subtype of pseudolymphoma cutis manifesting as a centrofacial acneiform eruption.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

Myriad of pigmented lesions in a patient with Costello syndrome.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.

The British journal of dermatology·2020

Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026

Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026

Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026

Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026

Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026

Same journal

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical and experimental immunology·2026

See all related articles

Autoimmune thyroiditis (AT) is common in vitiligo patients, often appearing after vitiligo onset. Elevated anti-nuclear antibody (ANA) levels correlate with atrophic AT and reduced thyroid volume in vitiligo patients.

Area of Science:

Immunology
Endocrinology
Dermatology

Background:

Vitiligo is frequently associated with autoimmune thyroiditis (AT).
Understanding the clinical course and co-occurrence of autoimmune disorders in vitiligo patients is crucial for comprehensive patient care.

Purpose of the Study:

To evaluate the clinical course of patients with coexisting vitiligo and AT.
To identify additional autoimmune disorders in a large cohort of vitiligo patients.
To investigate the impact of anti-nuclear antibody (ANA) levels on thyroid morphology in vitiligo patients.

Main Methods:

Analysis of 106 vitiligo patients and 38 controls.
Comprehensive thyroid examinations including sonography.
HLA typing and screening for various autoimmune disorders.

Related Experiment Videos

Main Results:

AT prevalence was significantly higher in vitiligo patients (21%) compared to controls (3%).
In most cases, vitiligo preceded AT diagnosis.
Elevated ANA levels were associated with the atrophic variant of AT and significantly reduced thyroid volume in vitiligo patients, a phenomenon not seen in controls.

Conclusions:

Autoimmune thyroiditis is the most frequent autoimmune disease associated with vitiligo.
AT typically presents concurrently with or subsequent to vitiligo.
Elevated ANA levels may indicate atrophic AT and influence thyroid gland volume in vitiligo patients.